HomeInsightsPE

Kilitch Drugs (india) Ltd PE Ratio

Kilitch Drugs (india) Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

3.5 K

stocks traded

Last Updated time: 20 Sep 9.00 AM

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

PE

47.2

Last updated: 20 Sep 9.00 AM

Key Highlights

  • The P/E Ratio of Kilitch Drugs (India) Ltd is 47.2 as of 20 Sep 9.00 AM.
  • The P/E Ratio of Kilitch Drugs (India) Ltd changed from 79.4 on March 2019 to 42.9 on March 2024 . This represents a CAGR of -9.75% over 6 years. .
  • The Latest Trading Price of Kilitch Drugs (India) Ltd is ₹ 369.65 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.7. In 2024.

Historical P/E Ratio of Kilitch Drugs (India) Ltd

No data available

Company Fundamentals for Kilitch Drugs (India) Ltd

No data available

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

PRICE

369.65

-2.15 (-0.58%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Kilitch Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024369.65
18 Sep 2024371.8
17 Sep 2024375.85
16 Sep 2024387.55
13 Sep 2024390.95
12 Sep 2024396
11 Sep 2024390.85
10 Sep 2024379.2
09 Sep 2024340
06 Sep 2024338.6

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kilitch Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kilitch Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Kilitch Drugs (India) Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Revenue of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Dividend Payout of Kilitch Drugs (India) Ltd

No data available

* All values are in %

About Kilitch Drugs (India) Ltd

  • Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company.
  • The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.
  • The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.
  • Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions.
  • The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables.

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 202415:38

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

02 Aug 202417:27

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 27 M...

Read more

20 May 202419:21

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Fe...

Read more

01 Feb 202419:34

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

03 Nov 202314:34

News

Kilitch Drugs (India) schedules AGM

Kilitch Drugs (India) announced that the 31st Annual General Meeting (AGM) of the company ...

Read more

17 Aug 202319:48

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Kilitch Drugs (India) Ltd

What is the current PE Ratio of Kilitch Drugs (India) Ltd?

The Current PE Ratio of Kilitch Drugs (India) Ltd is 47.21 as on 20 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 20 Sep 2024.

What was the PE Ratio of Kilitch Drugs (India) Ltd last year?

The PE Ratio of Kilitch Drugs (India) Ltd was 20.8 last year, now the PE ratio is 47.21, showing a year-on-year growth of 127.0%.

What does the PE Ratio of Kilitch Drugs (India) Ltd indicate about its stock?

The PE Ratio of Kilitch Drugs (India) Ltd is 47.21. This ratio indicates that investors are willing to pay 47.21 times the earnings per share for each share of Kilitch Drugs (India) Ltd.

What is the PE Ratio Growth of Kilitch Drugs (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Kilitch Drugs (India) Ltd grew by 127.0% whereas, the EPS ratio grew by -62.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*